Co-Authors
This is a "connection" page, showing publications co-authored by Gregory Sempowski and Barton Haynes.
Connection Strength
2.183
-
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19. Cell. 2020 06 25; 181(7):1458-1463.
Score: 0.884
-
CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis. J Immunol. 2004 Jan 15; 172(2):787-94.
Score: 0.284
-
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment. Annu Rev Med. 2022 01 27; 73:1-16.
Score: 0.241
-
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021 05 27; 184(11):2955-2972.e25.
Score: 0.237
-
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. 2021 06; 594(7864):553-559.
Score: 0.236
-
Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J Immunol. 2006 Jul 01; 177(1):169-76.
Score: 0.084
-
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 08 05; 184(16):4203-4219.e32.
Score: 0.059
-
Cold sensitivity of the SARS-CoV-2 spike ectodomain. Nat Struct Mol Biol. 2021 02; 28(2):128-131.
Score: 0.058
-
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020 10 13; 53(4):724-732.e7.
Score: 0.056
-
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017 03 09; 543(7644):248-251.
Score: 0.044